Compare deBridge (DBR) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
deBridge vs Mira — how do they compare? deBridge trades at Rp269.73 (market cap Rp518,43M, Rp19,92M 24h volume), while Mira trades at Rp705.54 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: deBridge is far larger — about 2.3× Mira's market cap, and deBridge's circulating supply is 1,9B / 10B DBR (20%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold deBridge for 10 Days and Mira for 22 Days on average.
| DBR | MIRA | |
|---|---|---|
Market Cap | Rp518,43M | Rp226,43M |
Volume (24h) | Rp19,92M | Rp101,47M |
Circulating Supply | 1,9B / 10B DBR (20%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 10 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
deBridge (DBR) is trading at Rp273.38 with a market cap of Rp525.42 million, exhibiting a bullish technical signal driven by moving averages, though oscillators are neutral. The token has a circulating supply of 1.9 million out of 10 million, with a 20% circulation rate and average hold time of 10 days. No major protocol updates or ecosystem news were found recently.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high RSI levels suggesting overbought conditions and low liquidity. Key opportunities lie in potential network growth, while major risks involve volatility and limited market depth. Investors should monitor support at Rp268 and resistance at Rp278.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About deBridge
deBridge is the internet of liquidity for DeFi, enabling real-time transfer of assets and data across chains. By removing the risks of liquidity pools, it powers secure cross-chain interactions with deep liquidity, tight spreads, and guaranteed rates.
Read more on DBR →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
